Cargando…
Current and Future Trends in Biomarkers for the Early Detection of Alzheimer’s Disease in Asia: Expert Opinion
Alzheimer’s disease (AD) poses a substantial healthcare burden in the rapidly aging Asian population. Early diagnosis of AD, by means of biomarkers, can lead to interventions that might alter the course of the disease. The amyloid, tau, and neurodegeneration (AT[N]) framework, which classifies bioma...
Autores principales: | Kandiah, Nagaendran, Choi, Seong Hye, Hu, Chaur-Jong, Ishii, Kenji, Kasuga, Kensaku, Mok, Vincent C.T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9741748/ https://www.ncbi.nlm.nih.gov/pubmed/36606209 http://dx.doi.org/10.3233/ADR-220059 |
Ejemplares similares
-
Frontotemporal Dementia in Southeast Asia: A Comparative Study
por: Tan, Yee-Leng, et al.
Publicado: (2013) -
Expert opinion on the applicability of dyslipidemia guidelines in Asia and the Middle East
por: Alshamiri, Mostafa, et al.
Publicado: (2018) -
Discontinuation Rate of Newly Prescribed Donepezil in Alzheimer's Disease Patients in Asia
por: Park, Kee Hyung, et al.
Publicado: (2021) -
The present and the future of benzydamine: expert opinion paper
por: Bossi, Paolo, et al.
Publicado: (2023) -
BACE2: A Promising Neuroprotective Candidate for Alzheimer’s Disease
por: Yeap, Yee Jie, et al.
Publicado: (2023)